Caligan Partners LP Diversified Active

Location: New York, NY

CIK: 0001727492 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $520M (100.0% shares, 0.0% debt)

Holdings (17)

— VERONA PHARMA PLC 26.1%

Value $136M Shares 1,436,878 Est. Cost $16.60 Unrealized —

LQDA LIQUIDIA CORPORATION 19.4%

Value $101M Shares 8,118,892 Est. Cost $5.57 Unrealized +165.8%

EXEL EXELIXIS INC 12.9%

Value $67.25M Shares 1,525,730 Est. Cost $19.42 Unrealized +105.8%

AGIO AGIOS PHARMACEUTICALS INC 6.8%

Value $35.63M Shares 1,071,258 Est. Cost $28.94 Unrealized +4.7%

— MERUS N V 6.6%

Value $34.56M Shares 656,999 Est. Cost $46.55 Unrealized —

EOLS EVOLUS INC 5.9%

Value $30.78M Shares 3,341,970 Est. Cost $10.58 Unrealized -3.3%

MLYS MINERALYS THERAPEUTICS INC 5.2%

Value $27.29M Shares 2,017,352 Est. Cost $11.97 Unrealized +21.1%

RVMD REVOLUTION MEDICINES INC 4.5%

Value $23.43M Shares 636,835 Est. Cost $40.00 Unrealized -4.0%

ANIK ANIKA THERAPEUTICS INC 2.9%

Value $15.18M Shares 1,435,130 Est. Cost $25.57 Unrealized -50.7%

ABVX ABIVAX SA 2.5%

Value $12.81M Shares 1,674,400 Est. Cost $7.07 Unrealized —

— Y-MABS THERAPEUTICS INC 2.0%

Value $10.57M Shares 2,342,609 Est. Cost $8.13 Unrealized —

RZLT REZOLUTE INC 1.3%

Value $6.882M Shares 1,543,014 Est. Cost $3.77 Unrealized -1.6%

BCRX BIOCRYST PHARMACEUTICALS INC 1.1%

Value $5.725M Shares 638,908 Est. Cost $5.90 Unrealized +57.9%

SLS SELLAS LIFE SCIENCES GROUP I 1.0%

Value $5.037M Shares 2,300,000 Est. Cost — Unrealized —

— VERRICA PHARMACEUTICALS INC 0.9%

Value $4.898M Shares 9,239,119 Est. Cost $0.65 Unrealized —

TYRA TYRA BIOSCIENCES INC 0.3%

Value $1.818M Shares 189,950 Est. Cost $9.95 Unrealized -4.5%

AURA AURA BIOSCIENCES INC 0.2%

Value $1.252M Shares 200,000 Est. Cost $5.85 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	VERONA PHARMA PLC	1,436,878	$136M	26.1%	$16.60	—	SPONSORED ADS	925050106
LQDA	LIQUIDIA CORPORATION	8,118,892	$101M	19.4%	$5.57	+165.8%	COM NEW	53635D202
EXEL	EXELIXIS INC	1,525,730	$67.25M	12.9%	$19.42	+105.8%	COM	30161Q104
AGIO	AGIOS PHARMACEUTICALS INC	1,071,258	$35.63M	6.8%	$28.94	+4.7%	COM	00847X104
—	MERUS N V	656,999	$34.56M	6.6%	$46.55	—	COM	N5749R100
EOLS	EVOLUS INC	3,341,970	$30.78M	5.9%	$10.58	-3.3%	COM	30052C107
MLYS	MINERALYS THERAPEUTICS INC	2,017,352	$27.29M	5.2%	$11.97	+21.1%	COM	603170101
RVMD	REVOLUTION MEDICINES INC	636,835	$23.43M	4.5%	$40.00	-4.0%	COM	76155X100
ANIK	ANIKA THERAPEUTICS INC	1,435,130	$15.18M	2.9%	$25.57	-50.7%	COM	035255108
ABVX	ABIVAX SA	1,674,400	$12.81M	2.5%	$7.07	—	SPONSORED ADS	00370M103
—	Y-MABS THERAPEUTICS INC	2,342,609	$10.57M	2.0%	$8.13	—	COM	984241109
RZLT	REZOLUTE INC	1,543,014	$6.882M	1.3%	$3.77	-1.6%	COM NEW	76200L309
BCRX	BIOCRYST PHARMACEUTICALS INC	638,908	$5.725M	1.1%	$5.90	+57.9%	COM	09058V103
SLS	SELLAS LIFE SCIENCES GROUP I	2,300,000	$5.037M	1.0%	—	—	Call	81642T209
—	VERRICA PHARMACEUTICALS INC	9,239,119	$4.898M	0.9%	$0.65	—	COM	92511W108
TYRA	TYRA BIOSCIENCES INC	189,950	$1.818M	0.3%	$9.95	-4.5%	COM	90240B106
AURA	AURA BIOSCIENCES INC	200,000	$1.252M	0.2%	$5.85	0.0%	COM	05153U107